Literature DB >> 16314882

Sequence diversity and haplotype structure at the human CYP3A cluster.

E E Thompson1, H Kuttab-Boulos, L Yang, B A Roe, A Di Rienzo.   

Abstract

The four members of the human CYP3A subfamily play important roles in the clearance of xenobiotics, hormones, and environmental compounds. Many SNPs at the CYP3A locus have been characterized, with several showing large allele frequency differences across populations. In addition to the effects of CYP3A SNPs on drug metabolism, recent studies have highlighted the potential for CYP3A variation in susceptibility to several common phenotypes, including hypertension and cancer. We previously showed that the CYP3A4 and CYP3A5 genes have a strong haplotype structure at varying frequencies across ethnic groups. Here, we extend our re-sequencing survey to the remaining CYP3A genes in the same cluster, CYP3A7 and CYP3A43. Our study identified a large number of SNPs in coding and conserved noncoding sequences, several of which are common. The combined data set allows us to investigate patterns of sequence variation and linkage disequilibrium at the entire CYP3A locus for use in future association studies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16314882     DOI: 10.1038/sj.tpj.6500347

Source DB:  PubMed          Journal:  Pharmacogenomics J        ISSN: 1470-269X            Impact factor:   3.550


  16 in total

1.  The missing association: sequencing-based discovery of novel SNPs in VKORC1 and CYP2C9 that affect warfarin dose in African Americans.

Authors:  M A Perera; E Gamazon; L H Cavallari; S R Patel; S Poindexter; R A Kittles; D Nicolae; N J Cox
Journal:  Clin Pharmacol Ther       Date:  2011-01-26       Impact factor: 6.875

2.  The influence of CYP3A5 genotype on dexamethasone induction of CYP3A activity in African Americans.

Authors:  Patrick J Roberts; Kristan D Rollins; Angela D M Kashuba; Mary F Paine; Andrew C Nelsen; Eric E Williams; Cassandra Moran; Jatinder K Lamba; Erin G Schuetz; Roy L Hawke
Journal:  Drug Metab Dispos       Date:  2008-05-19       Impact factor: 3.922

3.  Modulation of aflatoxin B1-mediated genotoxicity in primary cultures of human hepatocytes by diindolylmethane, curcumin, and xanthohumols.

Authors:  Kerstin Gross-Steinmeyer; Patricia L Stapleton; Julia H Tracy; Theo K Bammler; Stephen C Strom; Donald R Buhler; David L Eaton
Journal:  Toxicol Sci       Date:  2009-09-21       Impact factor: 4.849

4.  Prediction of CYP3A4 enzyme activity using haplotype tag SNPs in African Americans.

Authors:  M A Perera; R K Thirumaran; N J Cox; S Hanauer; S Das; C Brimer-Cline; V Lamba; E G Schuetz; M J Ratain; A Di Rienzo
Journal:  Pharmacogenomics J       Date:  2008-09-30       Impact factor: 3.550

5.  Pharmacokinetics of tacrolimus during pregnancy.

Authors:  Songmao Zheng; Thomas R Easterling; Jason G Umans; Menachem Miodovnik; Justina C Calamia; Kenneth E Thummel; Danny D Shen; Connie L Davis; Mary F Hebert
Journal:  Ther Drug Monit       Date:  2012-12       Impact factor: 3.681

6.  Association of genotypes of the CYP3A cluster with midazolam disposition in vivo.

Authors:  J Miao; Y Jin; R L Marunde; C J Gorski; S Kim; S Quinney; M Radovich; L Li; S D Hall
Journal:  Pharmacogenomics J       Date:  2009-06-09       Impact factor: 3.550

7.  A pharmacogenomic study on the pharmacokinetics of tacrolimus in healthy subjects using the DMETTM Plus platform.

Authors:  Y Choi; F Jiang; H An; H J Park; J H Choi; H Lee
Journal:  Pharmacogenomics J       Date:  2016-02-16       Impact factor: 3.550

8.  Ancestry-Adjusted Vitamin D Metabolite Concentrations in Association With Cytochrome P450 3A Polymorphisms.

Authors:  Robin Taylor Wilson; Loren D Masters; Jill S Barnholtz-Sloan; Anna C Salzberg; Terryl J Hartman
Journal:  Am J Epidemiol       Date:  2018-04-01       Impact factor: 4.897

Review 9.  Genome-wide scans for footprints of natural selection.

Authors:  Taras K Oleksyk; Michael W Smith; Stephen J O'Brien
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-01-12       Impact factor: 6.237

10.  Structural Basis for the Diminished Ligand Binding and Catalytic Ability of Human Fetal-Specific CYP3A7.

Authors:  Irina F Sevrioukova
Journal:  Int J Mol Sci       Date:  2021-05-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.